// App-Quantinova.ai

459 : Efficacy of platinum re-challenge in metastatic urothelial carcinoma (mUC): A retrospective comparison of chemotherapy regimens.

Researchers

Presenter

  • Risa Liang Wong

Principal Investigators

  • Olivia A Do

  • Sarah K Holt

  • Jorge Ramos

  • Simon J. Crabb

  • Cora N. Sternberg

  • Joaquim Bellmunt

  • Sylvain Ladoire

  • Ugo De Giorgi

  • Lauren C Harshman

  • Ulka N. Vaishampayan

  • Andrea Necchi

  • Sandy Srinivas

  • Sumanta K. Pal

  • Guenter Niegisch

  • Tanya B. Dorff

  • Matt D. Galsky

  • Evan Y. Yu

Medical Centers

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • University of Washington, Seattle, WA

  • Seattle Genetics, Bothell, WA

  • University of Southampton, Southampten, United Kingdom

  • Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY.

  • Hospital Del Mar, Barcelona, Spain

  • Georges-Francois Leclerc Cancer Center, Dijon, France

  • Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

  • Dana-Farber Cancer Institute, Boston, MA

  • University of Michigan, Ann Arbor, MI

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Stanford School of Medicine, Stanford, CA

  • City of Hope Comprehensive Cancer Center, Monrovia, CA

  • Department of Urology, Heinrich-Heine-University, Duesseldorf, Germany

  • Mount Sinai Medical Center, New York, NY

Locations

  • United States

  • United Kingdom

  • Spain

  • France

  • Italy

  • Germany

Companies

  • Seattle Genetics, In

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Advanced Urothelial Carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved